by DMCBiotech | Jan 31, 2022 | DMC Press Releases
31 January 2022 – DMC Biotechnologies, Inc. announces that strategic investors Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million. DMC previously...
by DMCBiotech | Jan 5, 2022 | DMC Press Releases
5 January 2022 – DMC Biotechnologies has appointed Ashley Jenkins as Chief Financial Officer (CFO). Ashley joins DMC from Felix Energy where she has worked since 2013. Ashley joins DMC’s Boulder, Colorado office. Ashley Jenkins has significant strategic experience in...
by DMCBiotech | Dec 2, 2021 | DMC Press Releases, News
2 December 2021 – DMC Biotechnologies has completed the first close of its Series B fundraising, raising $34 million (USD) with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay...
by DMCBiotech | May 13, 2021 | DMC Press Releases, News
13 May 2021 – DMC Biotechnologies has completed downstream processing for its first product, the amino acid L-alanine. The downstream processing was done at EW Biotech in Leuna, Germany following the successful demonstration of commercial scale fermentation at the...
by DMCBiotech | Apr 21, 2021 | DMC Press Releases, News
21 April 2021 – DMC Biotechnologies and Conagen Inc. have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. L-alanine is a naturally occurring amino acid used widely in homecare products, human nutrition, and...
